Trials / Unknown
UnknownNCT00336115
The Safety and Immunogenicity of Acellular Pertussis Vaccine in Bone Marrow Transplant Recipients
Safety and Immunogenicity of Adult Formulation Tetanus and Diphtheria Toxoids Adsorbed Combined With Acellular Pertussis (Tdap) Vaccine Following Blood and Morrow Transplantation in Adults
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- Queen Elizabeth II Health Sciences Centre · Academic / Other
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if pertussis (whooping cough) vaccine is safe and produces an appropriate immune response against pertussis in blood and marrow transplant patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Tetanus and Diphtheria Toxoids Adsorbed Combined with Acellular Pertussis (Adacel) |
Timeline
- Start date
- 2006-07-01
- Completion
- 2008-05-01
- First posted
- 2006-06-12
- Last updated
- 2007-10-23
Source: ClinicalTrials.gov record NCT00336115. Inclusion in this directory is not an endorsement.